Target Price | $238.10 |
Price | $193.70 |
Potential | 22.92% |
Number of Estimates | 39 |
39 Analysts have issued a price target Zscaler, Inc. 2026 . The average Zscaler, Inc. target price is $238.10. This is 22.92% higher than the current stock price. The highest price target is $270.00 39.39% , the lowest is $195.00 0.67% . | |
A rating was issued by 46 analysts: 32 Analysts recommend Zscaler, Inc. to buy, 14 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zscaler, Inc. stock has an average upside potential 2026 of 22.92% . Most analysts recommend the Zscaler, Inc. stock at Purchase. |
39 Analysts have issued a sales forecast Zscaler, Inc. 2025 . The average Zscaler, Inc. sales estimate is $2.6b . This is 9.40% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.7b 10.04% , the lowest is $2.6b 9.17% .
This results in the following potential growth metrics:
2024 | $2.2b | 34.07% |
---|---|---|
2025 | $2.6b | 22.23% |
2026 | $3.2b | 20.12% |
2027 | $3.8b | 20.10% |
2028 | $4.5b | 16.78% |
2029 | $5.3b | 17.92% |
11 Analysts have issued an Zscaler, Inc. EBITDA forecast 2025. The average Zscaler, Inc. EBITDA estimate is $666m . This is 74,683.19% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $695m 77,937.97% , the lowest is $650m 72,908.37% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-43.0m | 63.11% |
---|---|---|
2025 | $666m | 1,649.64% |
2026 | $840m | 26.26% |
2027 | $1.0b | 24.74% |
2024 | -1.98% | 72.48% |
---|---|---|
2025 | 25.12% | 1,367.86% |
2026 | 26.40% | 5.10% |
2027 | 27.42% | 3.86% |
17 Zscaler, Inc. Analysts have issued a net profit forecast 2025. The average Zscaler, Inc. net profit estimate is $-60.3m . This is 289.78% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $9.3m 159.98% , the lowest is $-130m 737.52% .
This results in the following potential growth metrics and future Net Margins:
2024 | $-60.3m | 72.14% |
---|---|---|
2025 | $-60.3m | 0.06% |
2026 | $-22.2m | 63.24% |
2027 | $26.2m | 218.13% |
2024 | -2.78% | 79.22% |
---|---|---|
2025 | -2.28% | 18.10% |
2026 | -0.70% | 69.30% |
2027 | 0.69% | 198.57% |
17 Analysts have issued a Zscaler, Inc. forecast for earnings per share. The average Zscaler, Inc. EPS is $-0.39 . This is 290.00% lower than earnings per share in the financial year 2024. The highest EPS forecast is $0.06 160.00% , the lowest is $-0.84 740.00% .
This results in the following potential growth metrics and future valuations:
2024 | $-0.39 | 72.14% |
---|---|---|
2025 | $-0.39 | 0.00% |
2026 | $-0.14 | 64.10% |
2027 | $0.17 | 221.43% |
Current | -1,946.66 | 913.20% |
---|---|---|
2025 | -515.92 | 73.50% |
2026 | -1,403.77 | 172.09% |
2027 | 1,188.05 | 184.63% |
Based on analysts' sales estimates for 2025, the Zscaler, Inc. stock is valued at an EV/Sales of 11.12 and an P/S ratio of 11.74 .
This results in the following potential growth metrics and future valuations:
Current | 12.17 | 11.17% |
---|---|---|
2025 | 11.12 | 8.60% |
2026 | 9.26 | 16.75% |
2027 | 7.71 | 16.74% |
2028 | 6.60 | 14.37% |
2029 | 5.60 | 15.20% |
Current | 12.85 | 10.43% |
---|---|---|
2025 | 11.74 | 8.59% |
2026 | 9.78 | 16.75% |
2027 | 8.14 | 16.73% |
2028 | 6.97 | 14.37% |
2029 | 5.91 | 15.20% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 16 2025 |
Rosenblatt |
Buy
➜
Buy
|
Unchanged | Apr 15 2025 |
Cantor Fitzgerald |
Neutral
➜
Overweight
|
Upgrade | Apr 03 2025 |
Stephens & Co. |
➜
Overweight
|
Initiated | Apr 01 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
B of A Securities |
Neutral
➜
Buy
|
Upgrade | Mar 07 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Mar 06 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 16 2025 |
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Apr 15 2025 |
Upgrade
Cantor Fitzgerald:
Neutral
➜
Overweight
|
Apr 03 2025 |
Initiated
Stephens & Co.:
➜
Overweight
|
Apr 01 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
Mar 31 2025 |
Upgrade
B of A Securities:
Neutral
➜
Buy
|
Mar 07 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Mar 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.